Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

This study has been completed.
Sponsor:
Collaborator:
St. Jude Medical
Information provided by:
Connolly, Stuart, M.D.
ClinicalTrials.gov Identifier:
NCT00257959
First received: November 22, 2005
Last updated: July 26, 2006
Last verified: November 2005